Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 60, Issue 3, Pages 305-317
Publisher
Springer Nature
Online
2011-01-17
DOI
10.1007/s00262-011-0974-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
- (2016) Sue-Anne McLachlan Therapeutics and Clinical Risk Management
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- NF-κB as a central regulator of macrophage function in tumors
- (2010) Subhra K. Biswas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
- (2010) Michio Naoe et al. ONCOLOGY RESEARCH
- Regulation of macrophage function in tumors: the multifaceted role of NF- B
- (2009) T. Hagemann et al. BLOOD
- Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
- (2009) T. M. Morgan et al. CLINICAL CANCER RESEARCH
- 2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
- (2009) A. Stopeck et al. EJC SUPPLEMENTS
- RANKL inhibition for the management of patients with benign metabolic bone disorders
- (2009) Athanasios D Anastasilakis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis
- (2009) A. D. Anastasilakis et al. HORMONE AND METABOLIC RESEARCH
- The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
- (2009) Kostantinos Zarogoulidis et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
- (2009) David P Dearnaley et al. LANCET ONCOLOGY
- Cancer micrometastases
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis
- (2008) H Kelchtermans et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanisms of T regulatory cell function
- (2008) Nadir Askenasy et al. AUTOIMMUNITY REVIEWS
- Osteoimmunology — The hidden immune regulation of bone
- (2008) Caetano-Lopes J. et al. AUTOIMMUNITY REVIEWS
- In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients
- (2008) Daniele Santini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Emerging role of bisphosphonates in the clinic—Antitumor activity and prevention of metastasis to bone
- (2008) Allan Lipton CANCER TREATMENT REVIEWS
- Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom
- (2008) B Rack et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
- (2008) Ann E. Kearns et al. ENDOCRINE REVIEWS
- Osteoimmunology: Interactions of the Bone and Immune System
- (2008) Joseph Lorenzo et al. ENDOCRINE REVIEWS
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- The cell biology of bone metabolism
- (2008) H K Datta et al. JOURNAL OF CLINICAL PATHOLOGY
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Shared gene expression profiles in developing heart valves and osteoblast progenitor cells
- (2008) Santanu Chakraborty et al. PHYSIOLOGICAL GENOMICS
- Molecular mechanisms of inflammatory bone damage: emerging targets for therapy
- (2008) Sonja Herman et al. TRENDS IN MOLECULAR MEDICINE
- RANK ligand as a therapeutic target for bone metastases and multiple myeloma
- (2007) G. David Roodman et al. CANCER TREATMENT REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started